Skip to content

Bronchiectasis Effect in COPD Patients

Effect of Bronchiectasis on Respiratory Functions, Exercise Capacity, Dyspnea Perception and Quality of Life in COPD Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03670940
Enrollment
35
Registered
2018-09-14
Start date
2015-01-31
Completion date
2018-04-30
Last updated
2018-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis, Copd

Brief summary

The etiology of bronchiectasis, known as permanent, abnormal, and localized development of bronchi, varies. However, most of them are responsible for infections during childhood. The prevalence of bronchiectasis is particularly high in advanced COPD patients. This phenomenon, called COPD-bronchiectasis overlap syndrome, affects the clinic of COPD patients negatively. In this study; bronchiectasis in respiratory function, exercise capacity, dyspnoea and quality of life in COPD patients.

Detailed description

The etiology of bronchiectasis, known as permanent, abnormal, and localized development of bronchi, varies. However, most of them are responsible for infections during childhood. The prevalence of bronchiectasis is particularly high in advanced COPD patients. This phenomenon, called COPD-bronchiectasis overlap syndrome, affects the clinic of COPD patients negatively. In this study; bronchiectasis in respiratory function, exercise capacity, dyspnoea and quality of life in COPD patients. Torax CTs of patients with COPD who are admitted to the outpatient clinic will be examined. There will be two groups, group 1 in patients with COPD accompanied by bronchiectasis and group 2 in COPD patients without bronchiectasis. In both groups, respiratory function tests, exercise capacities, dyspnea perceptions and quality of life will be evaluated. The data will be compared between the two groups.

Interventions

None listed

Sponsors

Izmir Katip Celebi University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* above 18 years old * clinically stable

Exclusion criteria

* other respiratory disease

Design outcomes

Primary

MeasureTime frameDescription
Exercise capacity15 minutessix minute walk test

Secondary

MeasureTime frameDescription
Dyspnea Severity5 minutesmMRC Dyspnea Scale (0: no dyspnea, 4: very severe dyspnea)
Lung Function20 minutesRespiratory Function Test
Health Related Quality of Life25 minutesSt. George Respiratory Questionnaire (maximum score: 100, lower score means better quality of life)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026